This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Myeloproliferative Disorder, Myelodysplastic Syndromes or Pulmonary Hypertension
and you are
between 18 and 95
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Myelodysplastic and myeloproliferative Disease represent conditions with increased risk for pulmonary hypertension. However, the exact prevalence of pulmonary hypertension in these conditions is not known. The effects of pulmonary hypertension on the clinical picture and the symptoms of patients in these conditions needs also further exploration. This exploratory study is designed to describe the prevalence of pulmonary hypertension in the population with such hematologic diseases, and the stages of pulmonary hypertension as well its effect on exercise capacity at time of diagnosis.

Provided treatments

  • Other: echocardiography, right heart catheterisation
Tris trial is registered with FDA with number: NCT00909467. The sponsor of the trial is Medical University of Graz and it is looking for 86 volunteers for the current phase.
Official trial title:
Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases